September 8, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — Generex Biotechnology Corp. (NASDAQ: GNBT), a firm offering technologies for drug delivery for metabolic diseases through the inner lining of the mouth, said that it has entered into a long-term marketing and distribution agreement with Merck,  S.A. de C.V. in Mexico for the distribution of one of the company's proprietary over-the-counter products, Glucose RapidSpray brand formulated glucose spray product. Under the deal, Merck (NYSE: MRK) will market and distribute the product in Mexico as Diabion GlucoShot.

Glucose RapidSpray delivers a glucose formulation that was developed using Generex’s proprietary buccal drug delivery technologies.

Massachusetts-based Generex is engaged in the research, development and commercialization of drug delivery systems and technologies.

=========

Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html). Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[hlmsmlh] [hlthcrdp] [nwdlsldw] [hlthcrdp] [tchnlgy] [ntrntnlcmpnsbsnss] [ltnmrcrmntl] [ftrdnwswnd] [sthcntrlmrc]